Rackliffe Philip 4
4 · GE HealthCare Technologies Inc. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
GE HealthCare (GEHC) CEO Philip Rackliffe Receives 16,458 RSUs
What Happened
- Philip Rackliffe, CEO (AIS) of GE HealthCare Technologies Inc. (GEHC), was granted 16,458 restricted stock units (RSUs) on May 15, 2026. The award is reported as an acquisition at $0.00 per unit (standard for equity awards reported as "A" — award/grant). The filing does not state a market-dollar value for the grant.
Key Details
- Transaction date: 2026-05-15; Form 4 filed: 2026-05-19 (filed within the reporting deadline).
- Grant: 16,458 RSUs; reported acquisition price: $0.00 per unit.
- Vesting (per footnote): 50% vest on May 15, 2028; 50% vest on May 15, 2029.
- Each RSU equals the right to receive one share of GE HealthCare common stock at settlement (per footnote).
- Shares owned after the transaction: not specified in the information provided in this filing.
- Transaction code: A (award/grant).
Context
- RSUs are a form of compensation that convert into actual shares only when they vest; they are not immediately tradable stock. This grant is a routine equity compensation event rather than an open‑market purchase or sale and should be viewed accordingly. The filing was submitted within the normal Form 4 deadline.
Insider Transaction Report
Form 4
Rackliffe Philip
CEO, AIS
Transactions
- Award
Common Stock, par value $0.01 per share
[F1][F2]2026-05-15+16,458→ 43,187 total
Footnotes (2)
- [F1]Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on May 15, 2028, and 50% will vest on May 15, 2029.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact|2026-05-19